Skip to main content
SpringerLink
Log in

Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies

  • Chapter
  • First Online:
Cell & Molecular Biology of Prostate Cancer

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1095))

Abstract

This chapter provides a brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies that are discussed in more detail in the subsequent chapters of this book and the companion book titled “Clinical Molecular and Diagnostic Imaging of Prostate Cancer and Treatment Strategies”. It also points to websites that provide additional useful information for patients affected by prostate cancer and for students and teachers to obtain practical and updated information on research, new diagnostic modalities and new therapies including new updated clinical trials. Three sections are focused on overview of prostate cancer statistics; overview of detection, diagnosis, stages and grading of prostate cancer; and treatment possibilities and options.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brayford S, Schevzov G, Vos J, Gunning P (2015) The role of the actin cytoskeleton in cancer and its potential use as a therapeutic target. In: Schatten H (ed) The cytoskeleton in health and disease. Springer Science+Business Media, New York

    Google Scholar 

  2. Collazo J, Zhu B, Larkin S, Martin SK, Pu H, Horbinski C, Koochekpour S, Kyprianou N (2014) Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. Cancer Res 74(8):2362–2373. https://doi.org/10.1158/0008-5472.CAN-13-3058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Darshan MS, Loftus MS, Thadani-Mulero M, Levy BP, Escuin D, Zhou XK, Gjyrezi A, Chanel-Vos C, Shen R, Tagawa ST, Bander NH, Nanus DM, Giannakakou P (2011) Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer. Cancer Res 71:6019–6029

    Article  CAS  Google Scholar 

  4. Denmeade SR, Isaacs JT (2002) A history of prostate cancer treatment. Nat Rev Cancer 2:389–396

    Article  CAS  Google Scholar 

  5. Feldmann BJ, Feldmann D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34–45

    Article  Google Scholar 

  6. Filella X, Foj L (2018). Novel biomarkers for prostate cancer detection and prognosis. In: Schatten H (ed) Cell and molecular biology of prostate cancer: Updates, insights and new frontiers. Springer Science+Business Media, New York

    Google Scholar 

  7. Garrison JB, Kyprianou N (2006) Doxazosin induces apoptosis of benign and malignant prostate cells via death receptor mediated pathway. Cancer Res 66:464–472

    Article  CAS  Google Scholar 

  8. Garrison JB, Shaw YJ, Chen CS, Kyprianou N (2007) Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. Cancer Res 67:11344–11352

    Article  CAS  Google Scholar 

  9. Giannico GA, Hameed O (2018) Evaluation of prostate needle biopsies. In: Schatten H (ed) Clinical molecular and diagnostic imaging of prostate Cancer and treatment strategies. Springer Science Business Media

    Google Scholar 

  10. Goodin S, Kane MP, Rubin EH (2004) Epothilones L mechanism of action and biologic activity. J Clin Oncol 22:2015–2025

    Article  CAS  Google Scholar 

  11. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13:7003–7011

    Article  CAS  Google Scholar 

  12. Hawsawi O, Henderson V, Sweeney J, Odero-Marah V (2018). Epithelial-mesenchymal Transition (EMT) and Prostate Cancer. In: Schatten H (ed) Cell and molecular biology of prostate cancer: Updates, insights and new frontiers. Springer Science+Business Media, New York

    Google Scholar 

  13. Hensley PJ, Desinoitis A, Wang C, Stromberg A, Chen CS, Kyprianou N (2014) Novel pharmacalogic targeting of tight junctions and focal adhesions in prostate cancer cells. PLoS One 9:e86238

    Article  Google Scholar 

  14. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265

    Article  CAS  Google Scholar 

  15. Martin SK, Fiandalo MV, Kyprianou N (2013) Androgen receptor signaling interactions control epithelial-mesenchymal transition (EMT) in prostate cancer progression. In: editors (ed) Androgen-responsive genes in prostate cancer. Springer, New York, pp 227–255

    Chapter  Google Scholar 

  16. Martin SK, Kamelgarn M, Kyprianou N (2014) Cytoskeleton targeting value in prostate cancer treatment. Am J Clin Exp Urol 2(1):15–26

    PubMed  PubMed Central  Google Scholar 

  17. Oft M, Heider KH, Beug H (1998) TGF beta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8:1243–1252

    Article  CAS  Google Scholar 

  18. Paller CJ, Antonarakis ES (2011) Cabazitaxel: a novel second line treatment for metastatic castration-resistant prostate cancer. Drug design. Drug Des Devel Ther 5:117

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Pellegrini F, Budman DR (2005). Tubulin function, action of antitubulin drugs, and new drug development. Cancer Invest 23(3):264–273.

    Google Scholar 

  20. Sarkar D (2018) The role of multi-parametric MRI and fusion biopsy for the diagnosis of prostate cancer. In: Schatten H (ed) Clinical molecular and diagnostic imaging of prostate Cancer and treatment strategies. Springer Science Business Media

    Google Scholar 

  21. Schatten H (2008) The mammalian centrosome and its functional significance. Histochem Cell Biol 129:667–686

    Article  CAS  Google Scholar 

  22. Schatten H (2014) The Role of Centrosomes in Cancer Stem Cell Functions. In: Schatten H (ed). ©Cell and Molecular Biology and Imaging of Stem Cells, First Edition. John Wiley & Sons, Inc, pp 259–279

    Google Scholar 

  23. Schatten H (2015) Brief overview of the cytoskeleton. In: Schatten H (ed) The cytoskeleton in health and disease. Springer Science+Business Media, New York

    Chapter  Google Scholar 

  24. Schatten H, Sun Q-Y (2011) The significant role of centrosomes in stem cell division and differentiation. Microsc Microanal 17(4):506–512 Epub 2011 Jul 11

    Article  CAS  Google Scholar 

  25. Schatten H, Sun QY (2015a) Centrosome and microtubule functions and dysfunctions in meiosis: implications for age-related infertility and developmental disorders. Reprod Fertil Dev 27:934. https://doi.org/10.1071/RD14493. PMID: 25903261

    Article  CAS  PubMed  Google Scholar 

  26. Schatten H, Sun Q-Y (2015b) Centrosome-microtubule interactions in health, disease, and disorders. In: Schatten H (ed) The cytoskeleton in health and disease. Springer Science+Business Media, New York

    Chapter  Google Scholar 

  27. Schatten H, Sun Q-Y (2017) Cytoskeletal functions, defects, and dysfunctions affecting human fertilization and embryo development. In: Schatten H (ed) Human reproduction: updates and new horizons. John Wiley & Sons Inc, Hoboken, NJ

    Chapter  Google Scholar 

  28. Schatten G, Schatten H, Bestor T, Balczon R (1982) Taxol inhibits the nuclear movements during fertilization and induces asters in unfertilized sea urchin eggs. J Cell Biol 94:455–465

    Article  CAS  Google Scholar 

  29. Schatten H, Ripple M, Balczon R, Weindruch R, Taylor M (2000) Androgen and taxol cause cell type specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent prostate cancer cells. Journal of Cellular Biochemistry 76:463–477

    Article  CAS  Google Scholar 

  30. Schiff PB, Fant J, Horowitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667

    Article  CAS  Google Scholar 

  31. Schütz V, Kesch C, Dieffenbacher S, Bonekamp D, Hadaschik BA, Hohenfellner M, Radtke JP (2018) Multiparametric MRI and MRI/TRUS fusion guided biopsy for the diagnosis of prostate cancer. In: Schatten H (ed) Clinical molecular and diagnostic imaging of prostate Cancer and treatment strategies. Springer Science Business Media

    Google Scholar 

  32. Yadav KK, Stockert JA, Yadav SS, Khan I, Tewari AK (2018) Inflammation and prostate cancer. In: Schatten H (ed) Cell and molecular biology of prostate Cancer: updates, insights and new Frontiers. Springer Science Business Media

    Google Scholar 

  33. Yoshioka K, Foletta V, Bernard O, Itoh K (2003) A role of LIM kinase in cancer invasion. PNAS 100:7247–7252

    Article  CAS  Google Scholar 

  34. Zhu B, Fukada K, Zhu H, Kyprianou N (2006) Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells. Cancer Res 66:8640–8647

    Article  CAS  Google Scholar 

  35. Zhu ML, Horbinski C, Garzotto M, Qian DZ, Beer TM, Kyprianou N (2010) Tubulin targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Res 70:7992–8002

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA

    Heide Schatten

Authors
  1. Heide Schatten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heide Schatten .

Editor information

Editors and Affiliations

  1. Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA

    Heide Schatten

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schatten, H. (2018). Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies. In: Schatten, H. (eds) Cell & Molecular Biology of Prostate Cancer. Advances in Experimental Medicine and Biology, vol 1095. Springer, Cham. https://doi.org/10.1007/978-3-319-95693-0_1

Download citation

Publish with us

Policies and ethics

Search

Navigation